此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Striving to Quit-Wisconsin Tobacco Quit Line

2016年12月5日 更新者:University of Wisconsin, Madison

Striving to Quit: Wisconsin Tobacco Quit Line Tobacco Cessation Research

This study is designed to test the hypotheses that incentives can increase both participation in smoking cessation treatment and resulting cessation rates when they are offered to Medicaid BadgerCare Plus members.

研究概览

详细说明

Aim 1: To determine the extent to which contingent financial "treatment incentives" (i.e., incentives for biochemical verification visits, treatment engagement, and abstinence) versus "attendance incentives" (i.e., incentives for only attending the biochemical verification visits), increase rates of smoking cessation . Participants will be BadgerCare Plus tobacco users who enroll in Wisconsin Tobacco Quit Line (WTQL) services.

Aim 2: To determine the extent to which treatment incentives vs. attendance incentives increase rates of engagement in smoking cessation treatment through the WTQL when offered to BadgerCare Plus members who smoke.

Aim 3: To determine the cost-effectiveness of the smoking cessation program when paired with treatment incentives and when paired with attendance incentives.

Aim 4: To identify moderating and mediational effects regarding the clinical benefit of incentivized smoking treatment

Aim 5: To determine the reach of an incentivized smoking cessation treatment that depends upon primary care clinic staff, a fax-to-quit referral mechanism and a state quit line.

研究类型

介入性

阶段

  • 不适用

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

描述

Inclusion Criteria:

  • enrollment in Wisconsin Medicaid (BadgerCare Plus)
  • resides in study area (one of 25 counties)
  • member of participating HMOs
  • 18 or older
  • English speaking
  • has smoked daily (at least 5 cigarettes each day) over the last week
  • willingness to attend visits at his/her PCC (primary care clinic) every 6 months (3 times over a 12 month period), provide urine samples, and complete follow-up phone calls
  • willingness to inform the WTQL as to any change in address, phone number, clinic attended, or health plan.

Exclusion Criteria:

  • not enrolled in Wisconsin Medicaid (BadgerCare Plus)
  • not reside in study area
  • not a member participating HMOs
  • less than 18 years of age
  • not English speaking
  • does not smoke daily (at least 5 cigarettes each day) over the last week
  • not willing to attend visits at his/her PCC (primary care clinic) every 6 months (3 times over a 12 month period), provide urine samples, and complete follow-up phone calls.
  • not willing to inform the WTQL as to any change in address, phone number, clinic attended, or health plan.

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:治疗
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:单身的

武器和干预

参与者组/臂
干预/治疗
实验性的:Treatment incentives
Incentives for biochemical verification visits, treatment engagement, and abstinence
Treatment incentives - incentives for biochemical verification visits, treatment engagement and abstinence
有源比较器:Attendance incentive
Incentives for only attending the biochemical verification visits
Attendance Incentives - incentives for only attending the biochemical verification visits

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Abstinence from smoking
大体时间:Measured 6 months after enrollment at follow-up assessment
The data will be the biochemically confirmed reports of abstinence for the past 7 days (i.e., 7-day point-prevalence abstinence)
Measured 6 months after enrollment at follow-up assessment

次要结果测量

结果测量
措施说明
大体时间
Engagement in treatment
大体时间:Measured 12 months after enrollment at follow-up assessment
The primary analyses will compare number of calls completed
Measured 12 months after enrollment at follow-up assessment
Cost-effectiveness
大体时间:Measured 12 months after enrollment
The primary analysis will contrast the incremental costs of the treatment vs. attendance conditions by computing the Incremental Cost-Effectiveness Ratio (ICER) with regard to attaining 6-month abstinence.
Measured 12 months after enrollment

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Timothy B Baker, PhD、University of Wisconsin, Madison

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2012年9月1日

初级完成 (预期的)

2013年3月1日

研究完成 (实际的)

2013年3月1日

研究注册日期

首次提交

2012年3月30日

首先提交符合 QC 标准的

2012年3月30日

首次发布 (估计)

2012年4月3日

研究记录更新

最后更新发布 (估计)

2016年12月6日

上次提交的符合 QC 标准的更新

2016年12月5日

最后验证

2016年12月1日

更多信息

与本研究相关的术语

其他研究编号

  • 2012-0198

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

是的

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

3
订阅